Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Summary

The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.

Conditions

• Glaucoma
• Glaucoma Suspect
• Diabetic Retinopathy
• Ocular Hypertension
• Cataract
• Branch Retinal Vein Occlusion
• Branch Retinal Arterial Occlusion
• Central Retinal Vein Occlusion
• Central Retinal Artery Occlusion
• Epi-retinal Membrane
• Macular Degeneration
• Drusen
• Loss of Vision

Interventions

OTHER

Free Eye Screenings

This group will receive free eye screening and follow-up comprehensive ophthalmic exam if recommended.

OTHER

Enhanced Intervention

This group will receive ophthalmic referral and a navigator for assistance in scheduling appointments; confirming appointments via phone, mail, email and/or text message; arranging transportation through Customized Community Transportation (CCT) and Philadelphia Paratransit Service; and trained medical interpreters as needed.

OTHER

Usual Care

This group will receive ophthalmic referral.

Sponsors & Collaborators

• Centers for Disease Control and Prevention

  collaborator FED

• Westat

  collaborator OTHER

• Public Health Management Corporation

  collaborator OTHER

• Philadelphia Department of Public Health

  collaborator OTHER_GOV

• Health Federation of Philadelphia

  collaborator OTHER

• Temple Physicians, Inc.

  collaborator INDUSTRY

• Wills Eye

  lead OTHER

Principal Investigators

• L. J Katz, MD · Wills Eye Hospital

• Lisa A Hark, PhD · Wills Eye Hospital

• Julia A Haller, MD · Wills Eye Hospital

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2014-09-30

Primary Completion

2019-09-30

Completion

2020-08-31

Countries

• United States

Study Locations